Bristol Myers Squibb (BMY) Curent Deferred Tax Liability (2010 - 2012)

Bristol Myers Squibb (BMY) has reported Curent Deferred Tax Liability for 3 consecutive years, with -$10.0 million the latest figure, recorded in Q4 2012.

• On a quarterly basis, Curent Deferred Tax Liability fell 66.67% year-over-year to -$10.0 million in Q4 2012; TTM through Dec 2012 was -$10.0 million, a 66.67% decrease from a year earlier, with the FY2012 full-year figure at -$10.0 million, down 66.67% from the prior year.
• Curent Deferred Tax Liability was -$10.0 million for Q4 2012 at Bristol Myers Squibb, down from -$6.0 million in the prior quarter.
• Over five years, Curent Deferred Tax Liability peaked at -$5.0 million in Q4 2010 and troughed at -$10.0 million in Q4 2012.
• A 3-year average of -$7.0 million and a median of -$6.0 million in 2011 frame the typical range for Curent Deferred Tax Liability.
• Across the five-year window, Curent Deferred Tax Liability slipped 20.0% in 2011 and slumped 66.67% in 2012, its largest moves.
• Over 3 years, Curent Deferred Tax Liability stood at -$5.0 million in 2010, then retreated by 20.0% to -$6.0 million in 2011, then slumped by 66.67% to -$10.0 million in 2012.
• The last three Curent Deferred Tax Liability figures came in at -$10.0 million (Q4 2012), -$6.0 million (Q4 2011), and -$5.0 million (Q4 2010), per Business Quant data.